SUFU 2008 Winter Meeting Highlights Of The Overactive Bladder Podium Session

Main Category: Urology / Nephrology
Also Included In: Conferences
Article Date: 08 Mar 2008 - 1:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

UroToday.com - Podium #17: The authors presented their results comparing the efficacy of different injection volumes, namely 01.cc, 0.5 cc, and 1.0 cc, of botulinum toxin type A (BTX-A) in patients with OAB. All three injection groups demonstrated significant symptom improvement at 8 weeks after treatment, which persisted in the 0.1cc and 1.0cc groups at 6 months.

All three groups also had significant improvement in urodynamic findings at 8 weeks after treatment compared to pre-operative evaluation.

Moderated by: R. Duane Cespedes, MD and Sandip P. Vasavada, MD at the Society for Urodynamics and Female Urology (SUFU) 2008 Winter Meeting - February 28 - March 2, 2008 Miami, Florida, USA

Reported for UroToday.com by Kathleen C. Kobashi, MD, Head, Section of Urology and Renal Transplantation, Virginia Mason Medical Center

Co-Director Continence Center, Virginia Mason Medical Center Clinical Associate Professor of Urology, University of Washington

UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice.

To access the latest urology news releases from UroToday, go to: www.urotoday.com

Copyright © 2008 - UroToday